Home > Archive>Volume 12, Issue 5, 2019 >784-788. DOI:10.18240/ijo.2019.05.13
PDF HTML XML Export Cite reminder
Efficacy and safety of micropulse laser trabeculoplasty for primary open angle glaucoma
Author:
Corresponding Author:

Chun Zhang. Ophthalmology Department, Peking University Third Hospital, No.49 North Garden Road, Haidian District, Beijing 100191, China. zhangc1@yahoo.com

Fund Project:

Supported by National Natural Science Foundation of China (No.81670851).

  • Article
    • | |
  • Metrics
    • |
  • Reference [28]
    • |
  • Related [20]
    • | | |
  • Comments
    Abstract:

    AIM: To evaluate the efficiency and safety of micropulse laser trabeculoplasty (MLT) for primary open angle glaucoma (POAG) patients. METHODS: Retrospective study. POAG patients undergoing MLT in Peking University Third Hospital from June 2016 to November 2017. Seventy-two eyes of 72 POAG patients were enrolled. Only one eye of each patient was treated by MLT. The intraocular pressure (IOP) before MLT and at 1d, 1, 4, 12 and 24wk and glaucoma medication before and after treatment were compared. RESULTS: The IOP was 20.6±5.9 mm Hg before MLT and 20.8±6.8 mm Hg at 2h after MTL. The IOP at 1d, 1, 4, 12 and 24wk was 17.9±4.4, 18.0±4.3, 17.5±3.4, 17.0±2.7, and 16.5±2.9 mm Hg, respectively. The IOP before and after MLT demonstrated a statistically significant difference by ANOVA analyses (F=5.797, P<0.001). Least significant difference t-tests showed there was no statistically significant difference between pre-MLT IOP within 2h after MLT (P=0.207). The statistically significant difference was confirmed between the pre-MLT IOP at 1d, 1, 4, 12 and 24wk after MLT (P=0.006, 0.009, 0.001, <0.001, <0.001, respectively). The number of glaucoma medications before MLT was 1.7±1.4 and 1.5±1.4 24wk after MLT with a significantly statistical difference (t=2.219, P=0.031) CONCLUSION: MLT is effective and safe for POAG patients. No patient experienced IOP spikes after MLT. The IOP 6mo after treatment decreased significantly with less glaucoma medication.

    Reference
    1 Cho HK, Kee C. Population-based glaucoma prevalence studies in Asians. Surv Ophthalmol 2014;59(4):434-447.
    2 Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA 2014;311(18):1901-1911.
    3 Alaei M, Najmi AK, Kausar H, Akhtar M. A prospective research study of anti-glaucoma drugs prescribing, utilization pattern and adverse drug reaction recording in a university hospital. Drug Res (Stuttg) 2015;65(3): 164-168.
    4 Giovingo M. Complications of glaucoma drainage device surgery: a review. Semin Ophthalmol 2014;29(5-6):397-402.
    5 Wang W, He M, Zhou MW, Zhang XL. Selective laser trabeculoplasty versus argon laser trabeculoplasty in patients with open-angle glaucoma: a systematic review and meta-analysis. PLoS One 2013;8(12):e84270.
    6 Baykara M, Hamidi NA, Akova-Budak B, Sabur H, Poroy C. Early results of selective laser trabeculoplasty in patients resistant to deep sclerectomy. Eur J Ophthalmol 2014;24(3):371-374.
    7 Meyer JJ, Lawrence SD. What’s new in laser treatment for glaucoma? Curr Opin Ophthalmol 2012;23(2):111-117.
    8 Tsang S, Cheng J, Lee JW. Developments in laser trabeculoplasty. Br J Ophthalmol 2016;100(1):94-97.
    9 Detry-Morel M, Muschart F, Pourjavan S. Micropulse diode laser (810 nm) versus argon laser trabeculoplasty in the treatment of open-angle glaucoma: comparative short-term safety and efficacy profile. Bull Soc Belge Ophtalmol 2008(308):21-28.
    10 Kaplowitz K, Wang S, Bilonick R, Oatts JT, Grippo T, Loewen NA. Randomized controlled comparison of titanium-sapphire versus standard Q-switched ND:YAG laser trabeculoplasty. J Glaucoma 2016;25(7):e663-e667.
    11 Lee JW, Yau GS, Yick DW, Yuen CY. MicroPulse laser trabeculoplasty for the treatment of open-angle glaucoma. Medicine (Baltimore) 2015;94(49):e2075.
    12 Luttrull JK, Sramek C, Palanker D, Spink CJ, Musch DC. Long-term safety, high-resolution imaging, and tissue temperature modeling of subvisible diode micropulse photocoagulation for retinovascular macular edema. Retina 2012;32(2):375-386.
    13 Koss MJ, Beger I, Koch FH. Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy. Eye (Lond) 2012;26(2): 307-314.
    14 Li XY, Wang W, Zhang XL. Meta-analysis of selective laser trabeculoplasty versus topical medication in the treatment of open-angle glaucoma. BMC Ophthalmol 2015;15:107.
    15 Fea AM, Bosone A, Rolle T, Brogliatti B, Grignolo FM. Micropulse diode laser trabeculoplasty (MDLT): A phase II clinical study with 12 months follow-up. Clin Ophthalmol 2008;2(2):247-252.
    16 Rantala E, Välimäki J. Micropulse diode laser trabeculoplasty: 180-degree treatment. Acta Ophthalmol 2012;90(5):441-444.
    17 Babalola OE. Micropulse diode laser trabeculoplasty in Nigerian patients. Clin Ophthalmol 2015;9:1347-1351.
    18 Zhang L, Weizer JS, Musch DC. Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty. status and date: New 2013. Available at: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD010746/full.
    19 Narayanaswamy A, Leung CK, Istiantoro DV, Perera SA, Ho CL, Nongpiur ME, Baskaran M, Htoon HM, Wong TT, Goh D, Su DH, Belkin M, Aung T. Efficacy of selective laser trabeculoplasty in primary angle-closure glaucoma: a randomized clinical trial. JAMA Ophthalmol 2015;133(2):206-212.
    20 Latina MA, Sibayan SA, Shin DH, Noecker RJ, Marcellino G. Q-switched 532-nm Nd: YAG laser trabeculoplasty (selective laser trabeculoplasty): a multicenter, pilot, clinical study. Ophthalmology 1998;105(11):2082-2088; discussion 2089-2090.
    21 Wong MO, Lee JW, Choy BN, Chan JC, Lai JS. Systematic review and meta-analysis on the efficacy of selective laser trabeculoplasty in open-angle glaucoma. Surv Ophthalmol 2015;60(1):36-50.
    22 Greninger DA, Lowry EA, Porco TC, Naseri A, Stamper RL, Han Y. Resident-performed selective laser trabeculoplasty in patients with open-angle glaucoma. JAMA Ophthalmol 2014;132(4):403-408.
    23 Samples JR, Singh K, Lin SC, Francis BA, Hodapp E, Jampel HD, Smith SD. Laser trabeculoplasty for open-angle glaucoma: a report by the american academy of ophthalmology. Ophthalmology 2011;118(11): 2296-2302.
    24 Kramer TR, Noecker RJ. Comparison of the morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eyes. Ophthalmology 2001;108(4):773-779.
    25 Latina MA, Park C. Selective targeting of trabecular meshwork cells: in vitro studies of pulsed and CW laser interactions. Exp Eye Res 1995;60(4):359-371.
    26 Russo V, Barone A, Cosma A, Stella A, Delle Noci N. Selective laser trabeculoplasty versus argon laser trabeculoplasty in patients with uncontrolled open-angle glaucoma. Eur J Ophthalmol 2009;19(3):429-434.
    27 Fudemberg SJ, Myers JS, Katz LJ. Trabecular meshwork tissue examination with scanning electron microscopy: a comparison of micropulse diode laser (MLT), selective laser (SLT), and argon laser (ALT) trabeculoplasty in human cadaver tissue. Invest Ophthalmol Vis Sci 2008;49(13):1236.
    28 Alvarado JA, Alvarado RG, Yeh RF, Franse-Carman L, Marcellino GR, Brownstein MJ. A new insight into the cellular regulation of aqueous outflow: how trabecular meshwork endothelial cells drive a mechanism that regulates the permeability of Schlemm’s canal endothelial cells. Br J Ophthalmol 2005;89(11):1500-1505.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Ying Hong, Si-Jia Song, Bo Liu,/et al.Efficacy and safety of micropulse laser trabeculoplasty for primary open angle glaucoma. Int J Ophthalmol, 2019,12(5):784-788

Copy
Share
Article Metrics
  • Abstract:1294
  • PDF: 674
  • HTML: 368
  • Cited by: 0
Publication History
  • Received:January 07,2019
  • Revised:March 12,2019
  • Online: March 27,2019
You are the 4468955 Visitors
Governing Body：Department of Health, Provincial Government of Shaanxi, China
Organizer：Xi'an Medical Association of China
Address：Room 11707-08, Building 2, Unit 1, Wanda Plaza, No.8 Yanta North Road, Xi'an 710054, Shaanxi Province, China
Fax：(8629)82245172 Phone：(+8629)82245172/82210956
Email：ijopress@163.com
International Journal of Ophthalmology ® 2025 All Rights Reserved   The terms of CC BY-NC-ND 4.0 are applicable to all open access content.